SAM
MRTX

Sectoral Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Sectoral Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,474
Closed -$380K – 116
2023
Q4 		$380K Sell
6,474
-175,430
-96% -$9.86M 0.16% 87
2023
Q3 		$7.92M Buy
181,904
+33,351
+22% +$1.19M 1.54% 21
2023
Q2 		$5.37M Buy
148,553
+20,147
+16% +$830K 0.89% 52
2023
Q1 		$4.77M Buy
128,406
+61,560
+92% +$2.77M 0.92% 49
2022
Q4 		$3.03M Buy
66,846
+7,330
+12% +$474K 0.59% 68
2022
Q3 		$4.16M Sell
59,516
-9,097
-13% -$673K 0.82% 55
2022
Q2 		$4.61M Buy
68,613
+8,776
+15% +$558K 0.93% 46
2022
Q1 		$4.92M Sell
59,837
-16,000
-21% -$1.64M 0.87% 47
2021
Q4 		$11.1M Buy
75,837
+73,286
+2,873% +$11.4M 1.67% 20
2021
Q3 		$451K Buy
2,551
+120
+5% +$19.3K 0.04% 119
2021
Q2 		$393K Sell
2,431
-76,650
-97% -$12.3M 0.03% 118
2021
Q1 		$13.5M Buy
79,081
+5,443
+7% +$1.08M 1.03% 33
2020
Q4 		$16.2M Buy
+73,638
New +$15.9M 1.14% 33
2020
Q3 		– Sell
-125,336
Closed -$14.3M – 186
2020
Q2 		$14.3M Buy
125,336
+51,236
+69% +$4.97M 1.31% 33
2020
Q1 		$5.7M Buy
+74,100
New +$6.65M 1.09% 44

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sectoral Asset Management's MRTX Position: Q1 2024 in Review

Sectoral Asset Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 6,474 shares — an estimated $380K sold.

Sectoral Asset Management first reported a position in MRTX in Q1 2020 and held it in 15 quarters. The position peaked at $16.2M in Q4 2020. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Sectoral Asset Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Sectoral Asset Management sold 6,474 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $380K.
  • Sectoral Asset Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2020 and held it in 15 quarters.
  • Sectoral Asset Management's Mirati Therapeutics, Inc. Common Stock position peaked at $16.2M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Sectoral Asset Management's 13F filing for Q1 2024, filed 14 May 2024.